Ipilimumab and Local Radiation for Selected Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab and Lenalidomide in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ipilimumab and Imatinib Mesylate in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of an Anti-KIR Antibody Lirilumab in Combination With an Anti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Antibody in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
- Status
- COMPLETED
- Phase
- NA
Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2